1-6 of 6
Xueyan Yu
Close
Sort by
Journal Articles

Next Generation XPO1 Inhibitor Shows Improved Efficacy and In Vivo Tolerability in Hematologic Malignancies

Zachary A. Hing, BS, Ho Yee Joyce Fung, BA, Parvathi Ranganathan, PhD, Shaneice Mitchell, BS, Dalia El-Gamal, PhD, Jennifer A. Woyach, MD, Katie Williams, MS, Virginia M. Goettl, DVM, PhD, Jordan L. Smith, BS, Xueyan Yu, Xiaomei Meng, Qingxiang Sun, PhD, Tolga Cagatay, PhD, John B. MacMillan, PhD, Amy M. Lehman, MAS, David M. Lucas, PhD, Erkan Baloglu, PhD, Sharon Shacham, Michael Kauffman, MD PhD, John C. Byrd, MD, Yuh Min Chook, PhD, Ramiro Garzon, MD, Rosa Lapalombella, PhD
Journal: Blood
Blood (2015) 126 (23): 317.
https://doi.org/10.1182/blood.V126.23.317.317
Published: 2015
Journal Articles

Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

Brief Report
Parvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, Jessica Hofstetter, Alison Walker, Katherine Walsh, Bhavana Bhatnagar, Rebecca Klisovic, Sumithira Vasu, Mitch A. Phelps, Steven Devine, Sharon Shacham, Michael Kauffman, Guido Marcucci, William Blum, Ramiro Garzon
Journal: Blood
Blood (2015) 125 (17): 2689–2692.
https://doi.org/10.1182/blood-2014-10-607648
Published: 2015
Includes: Supplemental data
Journal Articles

Implications of the miR-10 family in chemotherapy response of NPM1 -mutated AML

Brief Report
Violaine Havelange, Parvathi Ranganathan, Susan Geyer, Deedra Nicolet, Xiaomeng Huang, Xueyan Yu, Stefano Volinia, Steven M. Kornblau, Michael Andreeff, Carlo M. Croce, Guido Marcucci, Clara D. Bloomfield, Ramiro Garzon
Journal: Blood
Blood (2014) 123 (15): 2412–2415.
https://doi.org/10.1182/blood-2013-10-532374
Published: 2014
Includes: Supplemental data
Journal Articles

Serum Mir-29a Is Up-Regulated In Acute Graft Versus Host Disease (aGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) and Activates Dendritic Cells (DCs)

Yvonne A Efebera, MD, Parvathi Ranganathan, Ph.D, Xueyan Yu, Ph.D, Jessica Hofstetter, BS, Sabrina L Garman, BS, Laura Gibson, PhD, William Petros, Michael Craig, MD, Cecelia Fernandez-Cymering, BS, Mehdi Hamadani, MD, Guido Marcucci, MD, Steven M. Devine, MD, Muller Fabbri, MD, Ramiro Garzon, MD
Journal: Blood
Blood (2013) 122 (21): 4471.
https://doi.org/10.1182/blood.V122.21.4471.4471
Published: 2013
Journal Articles

Decitabine Priming Enhances The Antileukemic Effects Of The Selective Inhibitor Of Nuclear Export (SINE) CRM1/XPO1 Antagonist (Selinexor) In Acute Myeloid Leukemia (AML)

Parvathi Ranganathan, Ph.D, Xueyan Yu, Ph.D, Jessica Hofstetter, BS, Ramasamy Santhanam, Ph.D, Sharon Schacham, PhD, MBA, Michael Kauffman, MD, PhD, William Blum, MD, Guido Marcucci, MD, Ramiro Garzon, MD
Journal: Blood
Blood (2013) 122 (21): 1453.
https://doi.org/10.1182/blood.V122.21.1453.1453
Published: 2013
Journal Articles

Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia

Parvathi Ranganathan, Xueyan Yu, Caroline Na, Ramasamy Santhanam, Sharon Shacham, Michael Kauffman, Alison Walker, Rebecca Klisovic, William Blum, Michael Caligiuri, Carlo M. Croce, Guido Marcucci, Ramiro Garzon
Journal: Blood
Blood (2012) 120 (9): 1765–1773.
https://doi.org/10.1182/blood-2012-04-423160
Published: 2012